MetLife Investment Management’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.16M Buy
135,707
+513
+0.4% +$21.6K 0.03% 608
2025
Q4
$6.99M Sell
135,194
-5,347
-4% -$327K 0.03% 476
2025
Q3
$10.5M Buy
140,541
+133,435
+1,878% +$9.79M 0.05% 348
2025
Q2
$543K Sell
7,106
-485
-6% -$34.9K ﹤0.01% 1639
2025
Q1
$530K Buy
7,591
+63
+0.8% +$4.36K ﹤0.01% 1702
2024
Q4
$461K Buy
7,528
+135
+2% +$8.82K ﹤0.01% 1848
2024
Q3
$438K Sell
7,393
-153
-2% -$8.41K ﹤0.01% 1852
2024
Q2
$429K Buy
7,546
+368
+5% +$22.6K ﹤0.01% 1804
2024
Q1
$443K Buy
7,178
+19
+0.3% +$1.09K ﹤0.01% 1742
2023
Q4
$341K Buy
7,159
+281
+4% +$11.4K ﹤0.01% 1915
2023
Q3
$240K Buy
6,878
+6
+0.1% +$188 ﹤0.01% 2097
2023
Q2
$193K Sell
6,872
-2,656
-28% -$70.5K ﹤0.01% 2293
2023
Q1
$248K Buy
9,528
+22
+0.2% +$596 ﹤0.01% 2092
2022
Q4
$248K Buy
9,506
+477
+5% +$13K ﹤0.01% 2113
2022
Q3
$188K Buy
9,029
+104
+1% +$1.9K ﹤0.01% 2338
2022
Q2
$131K Sell
8,925
-4,920
-36% -$102K ﹤0.01% 2580
2022
Q1
$371K Buy
+13,845
New +$371K ﹤0.01% 1963
2019
Q2
Sell
-192
Closed -$7.25K 2545
2019
Q1
$7.25K Buy
192
+1
+0.5% +$46 ﹤0.01% 2437
2018
Q4
$7.94K Buy
191
+45
+31% +$1.86K ﹤0.01% 2408
2018
Q3
$6.24K Buy
+146
New +$7.71K ﹤0.01% 2503
2018
Q2
Sell
-48,555
Closed -$2.38M 2204
2018
Q1
$2.38M Hold
48,555
0.03% 714
2017
Q4
$1.71M Buy
+48,555
New +$1.47M 0.02% 837

Other funds holding NTNX

MetLife Investment Management's NTNX Position: Q1 2026 in Review

MetLife Investment Management increased its Nutanix (NTNX) stake by 0.38% in Q1 2026, buying an estimated $21.6K and bringing the position to 135,707 shares worth $5.16M. The position accounts for 0.03% of the portfolio, ranked #608.

MetLife Investment Management first reported a position in NTNX in Q4 2017 and has held it in 22 quarters since. The position peaked at $10.5M in Q3 2025. 534 funds tracked by Wall St. Rank hold NTNX as of Q1 2026.

  • MetLife Investment Management held 135,707 shares of Nutanix worth $5.16M as of Q1 2026.
  • MetLife Investment Management bought 513 Nutanix shares in Q1 2026, an estimated $21.6K.
  • Nutanix made up 0.03% of MetLife Investment Management's portfolio in Q1 2026, its #608 holding.
  • MetLife Investment Management first reported a position in Nutanix in Q4 2017 and has held it in 22 quarters since.
  • MetLife Investment Management's Nutanix position peaked at $10.5M in Q3 2025.
  • 534 funds tracked by Wall St. Rank held Nutanix as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.